Allelic Variants
|
There are no related allelic variants
|
|
Number of involved diseases in the family |
118 |
Number of CDK8 related diseases |
0 |
All kinase in this family
CDK8
Allelic Variants |
Disease Description |
Involved kinases (This family) |
Inhibitor of Involved Kinases |
Search Disease |
n/a | Epstein-Barr virus infection | AKT1, AKT2, AKT3, CDC2, CDK2, CHUK, CSNK2A1, CSNK2A2, EIF2AK2, FGR, GSK3B, JAK1, JAK3, LYN, MAP2K3, MAP2K6, MAP3K7, MAPK10, MAPK12, MAPK13, MAPK14, MAPK8, MAPK9 | 19 | Link | n/a | Influenza A | AKT1, AKT2, AKT3, EIF2AK2, GSK3B, IRAK4, JAK1, JAK2, MAP2K1, MAP2K3, MAP2K6, MAPK1, MAPK10, MAPK12, MAPK13, MAPK14, MAPK8, MAPK9, PRKCA, PRKCB | 57 | Link | n/a | Measles | AKT1, AKT2, AKT3, CDK2, CDK4, CDK6, CHUK, CSNK2A1, CSNK2A2, EIF2AK2, FYN, GSK3B, IRAK4, JAK1, JAK2, JAK3, MAP3K7, PRKCQ | 17 | Link | n/a | Tuberculosis | AKT1, AKT2, AKT3, CAMK2A, CAMK2B, CAMK2D, IRAK4, JAK1, JAK2, MAPK1, MAPK10, MAPK12, MAPK13, MAPK14, MAPK8, MAPK9, PLK3, SRC | 21 | Link | n/a | Toxoplasmosis | AKT1, AKT2, AKT3, CHUK, IRAK4, JAK1, JAK2, MAP2K3, MAP2K6, MAP3K7, MAPK1, MAPK10, MAPK12, MAPK13, MAPK14, MAPK8, MAPK9 | 13 | Link | | Leukemia | ABL1, ABL2, AKT1, AKT2, AKT3, CDK4, CDK6, CHUK, JAK2, MAP2K1, MAPK1, PIM1, PIM2, RPS6KB1, RPS6KB2 | 14 | Link | n/a | Hepatitis C | AKT1, AKT2, AKT3, CHUK, EIF2AK2, GSK3B, JAK1, MAPK1, MAPK10, MAPK12, MAPK13, MAPK14, MAPK8, MAPK9 | 13 | Link | n/a | Herpes simplex infection | CDC2, CDK2, CHUK, CSNK2A1, CSNK2A2, EIF2AK2, JAK1, JAK2, MAP3K7, MAPK10, MAPK8, MAPK9 | 15 | Link | | Prostate cancer | AKT1, AKT2, AKT3, CDK2, CHEK2, CHUK, FGFR1, FGFR2, GSK3B, MAP2K1, MAPK1, PDPK1 | 16 | Link | n/a | Shigellosis | ABL1, CHUK, MAPK1, MAPK10, MAPK12, MAPK13, MAPK14, MAPK8, MAPK9, ROCK1, ROCK2, SRC | 21 | Link | n/a | Chagas disease | AKT1, AKT2, AKT3, CHUK, IRAK4, MAPK1, MAPK10, MAPK12, MAPK13, MAPK14, MAPK8, MAPK9 | 10 | Link | n/a | Epithelial cell signaling in Helicobacter pylori infection | CHUK, LYN, MAPK10, MAPK12, MAPK13, MAPK14, MAPK8, MAPK9, MET, PAK1, SRC | 22 | Link | n/a | Salmonella infection | MAPK1, MAPK10, MAPK12, MAPK13, MAPK14, MAPK8, MAPK9, PKN1, PKN2, ROCK1, ROCK2 | 13 | Link | n/a | Leishmaniasis | IRAK4, JAK1, JAK2, MAP3K7, MAPK1, MAPK12, MAPK13, MAPK14, PRKCB | 13 | Link | | Melanoma | AKT1, AKT2, AKT3, CDK4, CDK6, FGFR1, MAP2K1, MAPK1, MET | 12 | Link | n/a | Pertussis | IRAK4, MAPK1, MAPK10, MAPK12, MAPK13, MAPK14, MAPK8, MAPK9 | 10 | Link | | Diabetes mellitus | AKT2, MAPK1, MAPK10, MAPK8, MAPK9, PRKCD, PRKCE | 13 | Link | | Lung cancer | AKT1, AKT2, AKT3, CDK2, CDK4, CDK6, CHUK | 11 | Link | n/a | Amyotrophic lateral sclerosis | MAP2K3, MAP2K6, MAPK12, MAPK13, MAPK14 | 10 | Link | n/a | Alcoholism | CAMKK1, CAMKK2, MAP2K1, MAPK1, NTRK2 | 11 | Link | n/a | Pathogenic Escherichia coli infection | ABL1, FYN, PRKCA, ROCK1, ROCK2 | 56 | Link | | Mental retardation | CASK, DYRK1A, PAK3, RPS6KA3 | 10 | Link | n/a | Prion diseases | FYN, MAP2K1, MAPK1 | 11 | Link | n/a | Viral myocarditis | ABL1, ABL2, FYN | 12 | Link | n/a | Immunodeficiencies | JAK3, LCK, ZAP70 | 14 | Link | | Colon cancer | AURKA, SRC | 19 | Link | | Crouzon syndrome | FGFR2, FGFR3 | 8 | Link | | Breast cancer | AKT1, CHEK2 | 8 | Link | n/a | Epileptic encephalopathy | CDKL5, MAPK10 | 6 | Link | n/a | Early infantile epileptic encephalopathy | CDKL5, MAPK10 | 6 | Link | n/a | Basal cell carcinoma | GSK3B, STK36 | 9 | Link | | Gastric cancer | FGFR2, MET | 9 | Link | n/a | Cervical cancer | CDK4, FGFR3 | 8 | Link | | Ovarian cancer | AKT1, AKT2 | 7 | Link | | Colorectal cancer | AKT1, FGFR3 | 7 | Link | n/a | Bladder cancer | DAPK1, FGFR3 | 9 | Link | | Pfeiffer syndrome | FGFR1, FGFR2 | 9 | Link | | Jackson-Weiss syndrome | FGFR1, FGFR2 | 9 | Link | | LADD syndrome | FGFR2, FGFR3 | 8 | Link | | Neuroblastoma | NTRK2, NTRK3 | 8 | Link | | SCID | JAK3, LCK | 14 | Link | n/a | African trypanosomiasis | PRKCA, PRKCB | 50 | Link | n/a | Vibrio cholerae infection | PRKCA, PRKCB | 50 | Link | n/a | Non-syndromic X-linked mental retardation | PAK3, RPS6KA3 | 9 | Link | n/a | Amoebiasis | PRKCA, PRKCB | 50 | Link | n/a | Autism suseptibility | MET | 8 | Link | n/a | Maturity onset diabetes of the young | BLK | 8 | Link | n/a | Malaria | MET | 8 | Link | n/a | Congenital myasthenic syndrome | MUSK | 4 | Link | | Hepatocellular carcinoma | MET | 8 | Link | n/a | FG syndrome | CASK | 1 | Link | n/a | Malignant melanoma | CDK4 | 5 | Link | n/a | Myasthenic syndrome | MUSK | 4 | Link | | Renal cell carcinoma | MET | 8 | Link | | Li-Fraumeni syndrome | CHEK2 | 5 | Link | n/a | Angelman syndrome-like | CDKL5 | 1 | Link | n/a | Cholangiocarcinoma | MET | 8 | Link | n/a | Glioma | CDK4 | 5 | Link | n/a | Cocaine addiction | CDK5 | 4 | Link | n/a | Prader-Willi and Angelman syndromes | CDKL5 | 1 | Link | n/a | Familial partial lipodystrophy | AKT2 | 7 | Link | | Hypoinsulinemic hypoglycemia | AKT2 | 7 | Link | n/a | Pituitary tumor | PRKCA | 50 | Link | | Glycogen storage disease | PHKG2 | 8 | Link | n/a | Cerebral infarction | PRKCH | 10 | Link | n/a | PTEN hamartoma tumor syndrome | AKT1 | 7 | Link | | Selective T-cell defect | ZAP70 | 10 | Link | n/a | Coffin-Lowry syndrome | RPS6KA3 | 7 | Link | n/a | Type I diabetes mellitus | PRKCQ | 8 | Link | n/a | Cirrhosis due to liver phosphorylase kinase deficiency | PHKG2 | 8 | Link | n/a | Glycogen storage diseases | PHKG2 | 8 | Link | | Osteosarcoma | CHEK2 | 5 | Link | n/a | Short rib-polydactyly syndorme | NEK1 | 3 | Link | n/a | Schizophrenia | AKT1 | 7 | Link | n/a | Proteus syndrome | AKT1 | 7 | Link | n/a | Obesity | NTRK2 | 8 | Link | n/a | Nephronophthisis | NEK8 | 1 | Link | n/a | Nephronophthisis-medullary cystic kidney disease | NEK8 | 1 | Link | | Cardiofaciocutaneous syndrome | MAP2K1 | 4 | Link | n/a | Invasive pneumococcal disease | IRAK4 | 4 | Link | n/a | Hypochondroplasia | FGFR3 | 7 | Link | n/a | Muenke syndrome | FGFR3 | 7 | Link | n/a | Nevus | FGFR3 | 7 | Link | n/a | Achondroplasia | FGFR3 | 7 | Link | n/a | CATSHL syndrome | FGFR3 | 7 | Link | n/a | Scaphocephaly and Axenfeld-Rieger anomaly | FGFR2 | 8 | Link | n/a | Multiple myeloma | FGFR3 | 7 | Link | n/a | FGFR3-related short limb skeletal dysplasias | FGFR3 | 7 | Link | n/a | Spermatocytic seminoma | FGFR3 | 7 | Link | n/a | Thanatophoric dysplasia | FGFR3 | 7 | Link | n/a | Endocrine-cerebroosteodysplasia | ICK | 2 | Link | | Lymphoproliferative syndrome | ITK | 5 | Link | | IRAK4 deficiency | IRAK4 | 4 | Link | | Polycythemia vera | JAK2 | 9 | Link | n/a | Oguchi disease | GRK1 | 4 | Link | n/a | Cancer progression/metastasis | FGFR4 | 3 | Link | n/a | Budd-Chiari syndrome | JAK2 | 9 | Link | n/a | Congenital stationary night blindness | GRK1 | 4 | Link | | Scaphocephaly | FGFR2 | 8 | Link | n/a | Saethre-Chotzen syndrome | FGFR2 | 8 | Link | | Osteoglophonic dysplasia | FGFR1 | 9 | Link | | Trigonocephaly | FGFR1 | 9 | Link | | REtinitis pigmentosa | MAK | 1 | Link | | Hypogonadotropic hypogonadism | FGFR1 | 9 | Link | n/a | Spondylometaepiphyseal dysplasia | DDR2 | 3 | Link | n/a | Cocoon syndrome | CHUK | 6 | Link | n/a | Legionellosis | CLK1 | 8 | Link | n/a | Noonan syndrome and related disorders | MAP2K1 | 4 | Link | | Kallmann syndrome | FGFR1 | 9 | Link | | Thrombocythemia | JAK2 | 9 | Link | | Craniosynostosis | FGFR2 | 8 | Link | n/a | Myeloproliferative disorder | JAK2 | 9 | Link | | Myelofibrosis | JAK2 | 9 | Link | | Craniofacial-skeletal-dermatologic dysplasia | FGFR2 | 8 | Link | | Bent bone dysplasia syndrome | FGFR2 | 8 | Link | n/a | Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis | FGFR2 | 8 | Link | | Apert syndrome | FGFR2 | 8 | Link | | Beare-Stevenson cutis gyrata syndrome | FGFR2 | 8 | Link |
|